We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.33%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.68B
AUM Growth
-$209M
Cap. Flow
-$341M
Cap. Flow %
-9.26%
Top 10 Hldgs %
13.58%
Holding
1,437
New
112
Increased
524
Reduced
590
Closed
111

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$7.02M
2
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$6.58M
3
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$4.15M
4
BAC icon
Bank of America
BAC
+$3.47M
5
THO icon
Thor Industries
THO
+$3.15M

Top Sells

Rank Stock Value
1
FMI
Foundation Medicine, Inc.
FMI
+$63.6M
2
GILD icon
Gilead Sciences
GILD
+$42.5M
3
AFL icon
Aflac
AFL
+$39.9M
4
KMX icon
CarMax
KMX
+$23.6M
5
WLY icon
John Wiley & Sons Class A
WLY
+$19.2M

Sector Composition

Rank Sector Weight
1 Technology 12.63%
2 Healthcare 11.47%
3 Financials 11.29%
4 Industrials 9.35%
5 Consumer Discretionary 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CFMS
1301
DELISTED
Conformis, Inc. Common Stock
CFMS
$52K ﹤0.01%
+1,650
New +$57K
IBRX icon
1302
ImmunityBio
IBRX
$7.8B
$51K ﹤0.01%
16,800
+6,500
+63% +$24.1K
LFWD icon
1303
ReWalk Robotics
LFWD
$19.7M
$51K ﹤0.01%
+25
New +$55.8K
BAC.WS.B
1304
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
$48K ﹤0.01%
78,500
– –
ATNM icon
1305
Actinium Pharmaceuticals
ATNM
$26.3M
$47K ﹤0.01%
+2,452
New +$31.1K
OIG
1306
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$46K ﹤0.01%
388
– –
MIND icon
1307
MIND Technology
MIND
$45M
$40K ﹤0.01%
+1,000
New +$36.9K
QUIK icon
1308
QuickLogic
QUIK
$228M
$39K ﹤0.01%
2,386
-357
-13% -$6.84K
PDLI
1309
DELISTED
PDL BioPharma, Inc.
PDLI
$36K ﹤0.01%
15,188
– –
TCRT icon
1310
Alaunos Therapeutics
TCRT
$4.59M
$33K ﹤0.01%
73
-14
-16% -$8.88K
TPST icon
1311
Tempest Therapeutics
TPST
$13.8M
$33K ﹤0.01%
12
-1
-8% -$2.63K
SCU
1312
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$31K ﹤0.01%
1,600
– –
NTG.RT
1313
DELISTED
Tortoise MLP Fund, Inc.
NTG.RT
$26K ﹤0.01%
+68,144
New +$28.6K
CGRN
1314
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$22K ﹤0.01%
1,534
-1,650
-52% -$24.6K
AMPE
1315
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$22K ﹤0.01%
34
-43
-56% -$32.2K
ATHX
1316
DELISTED
Athersys, Inc. Common Stock
ATHX
$20K ﹤0.01%
400
– –
CLDX icon
1317
Celldex Therapeutics
CLDX
$3.02B
$19K ﹤0.01%
2,396
-1,955
-45% -$26.1K
CCIH
1318
DELISTED
Chinacache International Holdings Ltd
CCIH
$17K ﹤0.01%
15,053
-42,394
-74% -$52.4K
BLRX
1319
BioLineRX
BLRX
$11.7M
$9K ﹤0.01%
+17
New +$9.03K
TMBR
1320
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$8K ﹤0.01%
2
– –
GSAT icon
1321
Globalstar
GSAT
$10.3B
$7K ﹤0.01%
1,014
– –
NEON icon
1322
Neonode
NEON
$13.4M
$6K ﹤0.01%
1,500
– –
AEG icon
1323
Aegon
AEG
$14B
– –
-33,155
Closed -$183K
AER icon
1324
AerCap
AER
$24.1B
– –
-7,306
Closed -$371K
ALLT icon
1325
Allot
ALLT
$367M
– –
-11,400
Closed -$61K
51 52
53
54 55

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
AIM
Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Oppenheimer & Co's Q2 2018 Portfolio in Review

As of Q2 2018, Oppenheimer & Co held 1,437 positions worth $3.68B, down 5.4% from $3.89B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co withdrew a net $341M in Q2 2018, closing 111 positions and reducing 590 holdings. Its most notable exit was Monsanto Co, an estimated $9.28M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Oppenheimer & Co opened a new position in Thor Industries worth $3.01M.

  • Oppenheimer & Co's largest Q2 2018 buy was Thor Industries: 30,900 shares worth $3.01M.
  • Oppenheimer & Co added most to AT&T in Q2 2018, an estimated $7.02M increase.
  • Oppenheimer & Co's biggest Q2 2018 reduction was Foundation Medicine, Inc., cutting an estimated $63.6M.
  • Oppenheimer & Co fully exited Monsanto Co in Q2 2018, selling an estimated $9.28M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.68B portfolio in Q2 2018.
  • Oppenheimer & Co opened 112 new positions and closed 111 in Q2 2018.
  • Oppenheimer & Co's portfolio value fell 5.4% quarter-over-quarter to $3.68B.

Based on Oppenheimer & Co's 13F filing for Q2 2018, filed 10 Aug 2018.